DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+9.69%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.51B
AUM Growth
+$465M
(+9.2%)
Cap. Flow
-$455M
Cap. Flow
% of AUM
-8.25%
Top 10 Holdings %
Top 10 Hldgs %
54.24%
Holding
168
New
43
Increased
28
Reduced
13
Closed
42
Top Buys
| 1 |
United Therapeutics
UTHR
|
$76.3M |
| 2 |
Merck
MRK
|
$67.9M |
| 3 |
Vera Therapeutics
VERA
|
$54.1M |
| 4 |
Legend Biotech
LEGN
|
$43.3M |
| 5 |
Centene
CNC
|
$27.9M |
Top Sells
| 1 |
Dynavax Technologies
DVAX
|
$67.3M |
| 2 |
Alignment Healthcare
ALHC
|
$59.1M |
| 3 |
Neurocrine Biosciences
NBIX
|
$40.4M |
| 4 |
CMRX
Chimerix, Inc.
CMRX
|
$32.1M |
| 5 |
InMode
INMD
|
$28M |
Sector Composition
| 1 | Healthcare | 89.05% |
| 2 | Real Estate | 0.41% |
| 3 | Financials | 0% |
| 4 | Industrials | 0% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Sotera Health
SHC
$4.37B
| $503K | 0.01% |
+45,242
| New | +$503K |
|
77
Cooper Companies
COO
$13.3B
| $450K | 0.01% |
+6,328
| New | +$450K |
|
78
Thermo Fisher Scientific
TMO
$182B
| $371K | 0.01% |
+916
| New | +$371K |
|
79
UFP Technologies
UFPT
$1.57B
| $370K | 0.01% |
+1,517
| New | +$370K |
|
80
Align Technology
ALGN
$9.69B
| $368K | 0.01% |
+1,945
| New | +$368K |
|
81
AtriCure
ATRC
$1.77B
| $365K | 0.01% |
+11,138
| New | +$365K |
|
82
LeMaitre Vascular
LMAT
$2.17B
| $346K | 0.01% |
+4,169
| New | +$346K |
|
83
OrthoPediatrics
KIDS
$512M
| $333K | 0.01% |
+15,486
| New | +$333K |
|
84
Enovis
ENOV
$1.8B
| $322K | 0.01% |
+10,267
| New | +$322K |
|
85
National Healthcare
NHC
$1.76B
| $313K | 0.01% |
+2,926
| New | +$313K |
|
86
DaVita
DVA
$9.75B
| $299K | 0.01% |
+2,101
| New | +$299K |
|
87
BioLife Solutions
BLFS
$1.21B
| $294K | 0.01% |
+13,670
| New | +$294K |
|
88
Universal Health Services
UHS
$11.8B
| $289K | 0.01% |
+1,597
| New | +$289K |
|
|
AMED
89
DELISTED
Amedisys
AMED
| $270K | ﹤0.01% |
+2,744
| New | +$270K |
|
90
Haemonetics
HAE
$2.58B
| $263K | ﹤0.01% |
+3,529
| New | +$263K |
|
91
IQVIA
IQV
$31B
| $256K | ﹤0.01% |
+1,623
| New | +$256K |
|
92
MiMedx Group
MDXG
$1.05B
| $240K | ﹤0.01% |
+39,351
| New | +$240K |
|
93
Medpace
MEDP
$13.3B
| $231K | ﹤0.01% |
+736
| New | +$231K |
|
94
Humana
HUM
$37.3B
| $224K | ﹤0.01% |
917
| – | – |
|
95
Amphastar Pharmaceuticals
AMPH
$1.35B
| $220K | ﹤0.01% |
+9,579
| New | +$220K |
|
|
QSIAW
96
Quantum-Si Incorporated Warrant
QSIAW
$75.2M
| $217K | ﹤0.01% |
333,333
| – | – |
|
97
Teleflex
TFX
$5.68B
| $214K | ﹤0.01% |
+1,805
| New | +$214K |
|
98
CorVel
CRVL
$4.42B
| $205K | ﹤0.01% |
+1,993
| New | +$205K |
|
99
Zoetis
ZTS
$67.7B
| $204K | ﹤0.01% |
+1,310
| New | +$204K |
|
100
Repligen
RGEN
$6.56B
| $202K | ﹤0.01% |
+1,628
| New | +$202K |
|